Retroviral-based gene therapy (Indiana University)

N/A

Report date: 2023/10/26 16:19:53

Base Information

Drug NameRetroviral-based gene therapy (Indiana University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionNADPH Oxidase 2 stimulants
TargetsNADPH Oxidase 2
Therapy Area/IndicationsGranulomatous Disease, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIndiana University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndiana University
Active IndicationsN/A
Inactive IndicationsGranulomatous Disease, Chronic

Other Information

ATC CodeN/A
Related LinksN/A